Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-012205
Filing Date
2021-02-18
Accepted
2021-02-18 20:43:49
Documents
1
Period of Report
2021-02-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 7709
  Complete submission text file 0001209191-21-012205.txt   9079
Mailing Address 1221 GULF SHORE BLVD N #303 NAPLES FL 34102
Business Address
Watkins Thomas (Reporting) CIK: 0001307935 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34186 | Film No.: 21651671

Mailing Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037
Business Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037 202-734-3400
Vanda Pharmaceuticals Inc. (Issuer) CIK: 0001347178 (see all company filings)

IRS No.: 030491827 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations